Soltis Investment Advisors LLC Abbott Laboratories Transaction History

Soltis Investment Advisors LLC

$1.38 Billion
Q3 2025

A detailed history of Soltis Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 8,644 shares of ABT stock, worth $1.12 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

8,644

Previous 8,620 0.28%

Holding current value

$1.12 Million

Previous $1.17 Million 1.28%

% of portfolio

0.08%

Previous 0.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$120.51 - $136.62 $2,892 - $3,278	24 Added 0.28%	8,644 $1.16 Million
Q2 2025 Aug 06, 2025	BUY	$123.95 - $138.08 $97,672 - $108,807	788 Added 10.06%	8,620 $1.17 Million
Q1 2025 May 13, 2025	SELL	$111.1 - $140.22 $95,546 - $120,589	-860 Reduced 9.89%	7,832 $1.04 Million
Q4 2024 Jan 29, 2025	SELL	$111.93 - $119.39 $51,823 - $55,277	-463 Reduced 5.06%	8,692 $983,000
Q3 2024 Nov 18, 2024	BUY	$100.07 - $118.13 $57,640 - $68,042	576 Added 6.71%	9,155 $1.04 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $21,858 - $24,399	217 Added 2.6%	8,579 $891,000
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $156,066 - $172,368	-1,425 Reduced 14.56%	8,362 $950,000
Q4 2023 Jan 26, 2024	SELL	$90.19 - $110.4 $72,332 - $88,540	-802 Reduced 7.57%	9,787 $1.08 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $34,772 - $41,721	364 Added 3.56%	10,589 $1.03 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $51,095 - $56,931	-507 Reduced 4.72%	10,225 $1.11 Million
Q1 2023 May 03, 2023	SELL	$96.86 - $114.01 $14,044 - $16,531	-145 Reduced 1.33%	10,732 $1.09 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $82,417 - $96,687	-867 Reduced 7.38%	10,877 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $8,418 - $9,746	-87 Reduced 0.74%	11,744 $1.14 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $44,502 - $53,789	436 Added 3.83%	11,831 $1.29 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $79,129 - $96,493	694 Added 6.49%	11,395 $1.35 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $38,355 - $46,964	-332 Reduced 3.01%	10,701 $1.51 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $8,749 - $9,679	75 Added 0.68%	11,033 $1.3 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $16,397 - $19,302	-155 Reduced 1.39%	10,958 $1.27 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $199,068 - $234,532	-1,829 Reduced 14.13%	11,113 $1.33 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $35,490 - $38,673	338 Added 2.68%	12,942 $1.42 Million
Q3 2020 Oct 28, 2020	BUY	$91.64 - $111.29 $862,424 - $1.05 Million	9,411 Added 294.74%	12,604 $1.37 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $244,488 - $312,914	3,193 New	3,193 $292,000

Others Institutions Holding ABT

# of Institutions

3,650

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soltis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soltis Investment Advisors LLC with notifications on news.

Account

Soltis Investment Advisors LLC Abbott Laboratories Transaction History